TNFRSF1A and metabolic dysfunction-associated steatotic liver disease: One of the major pathogenic drivers of the NAFLD pathology is tumour necrosis factor alpha (TNF-α), which mediates liver injury mainly via TNF-receptor-1 (TNFR1) signalling (93).